Funds and ETFs Enovis Corporation

Equities

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-06-25 EDT 5-day change 1st Jan Change
45 USD -0.04% Intraday chart for Enovis Corporation +0.87% -19.67%
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
45 USD
Average target price
72.18 USD
Spread / Average Target
+60.40%
Consensus
  1. Stock Market
  2. Equities
  3. ENOV Stock
  4. Funds and ETFs Enovis Corporation